Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.
Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, Shen CN, Lu PJ, Hsiao M.
Liu YP, et al. Among authors: lu j, lu pj.
Cancer Res. 2013 Jan 1;73(1):406-16. doi: 10.1158/0008-5472.CAN-12-1733. Epub 2012 Nov 7.
Cancer Res. 2013.
PMID: 23135908